These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28781296)

  • 41. Ultrastructural alterations of elastic fibers and other dermal components in ehlers-danlos syndrome of the hypermobile type.
    Hermanns-Lê T; Piérard GE
    Am J Dermatopathol; 2007 Aug; 29(4):370-3. PubMed ID: 17667170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
    Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
    Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
    Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
    N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
    Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
    Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome.
    Vogel A; Holbrook KA; Steinmann B; Gitzelmann R; Byers PH
    Lab Invest; 1979 Feb; 40(2):201-6. PubMed ID: 431039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zinc and Its Transporters in Epigenetics.
    Brito S; Lee MG; Bin BH; Lee JS
    Mol Cells; 2020 Apr; 43(4):323-330. PubMed ID: 32274919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene.
    Walker LC; Teebi AS; Marini JC; De Paepe A; Malfait F; Atsawasuwan P; Yamauchi M; Yeowell HN
    Mol Genet Metab; 2004 Dec; 83(4):312-21. PubMed ID: 15589118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome.
    Wenstrup RJ; Florer JB; Cole WG; Willing MC; Birk DE
    J Cell Biochem; 2004 May; 92(1):113-24. PubMed ID: 15095409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome.
    Morissette R; Schoenhoff F; Xu Z; Shilane DA; Griswold BF; Chen W; Yang J; Zhu J; Fert-Bober J; Sloper L; Lehman J; Commins N; Van Eyk JE; McDonnell NB
    Circ Cardiovasc Genet; 2014 Feb; 7(1):80-8. PubMed ID: 24399159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
    Zoppi N; Ritelli M; Colombi M
    Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis.
    Martínez-Salgado C; Fuentes-Calvo I; García-Cenador B; Santos E; López-Novoa JM
    Exp Cell Res; 2006 Jul; 312(11):2093-106. PubMed ID: 16624289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome.
    Huijing PA; Voermans NC; Baan GC; Busé TE; van Engelen BG; de Haan A
    J Appl Physiol (1985); 2010 Oct; 109(4):986-95. PubMed ID: 20576846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of dexamethasone on the assembly of the matrix of fibronectin and on its receptors organization in Ehlers-Danlos syndrome skin fibroblasts.
    Zoppi N; Ghinelli A; Gardella R; Barlati S; Colombi M
    Cell Biol Int; 1998; 22(7-8):499-508. PubMed ID: 10452818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
    Lund AM
    Ugeskr Laeger; 2006 Feb; 168(9):915-20. PubMed ID: 16513057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Ehlers-Danlos syndrome.
    Malfait F; De Paepe A
    Adv Exp Med Biol; 2014; 802():129-43. PubMed ID: 24443025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ZIP13: A Study of
    Xiao G; Zhou B
    Front Genet; 2017; 8():234. PubMed ID: 29445391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
    Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
    J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Ehlers-Danlos syndrome, a disorder with many faces.
    De Paepe A; Malfait F
    Clin Genet; 2012 Jul; 82(1):1-11. PubMed ID: 22353005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pumping iron.
    Philpott CC
    Elife; 2014 Aug; 3():e03997. PubMed ID: 25128012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis.
    Yasuoka H; Jukic DM; Zhou Z; Choi AM; Feghali-Bostwick CA
    Arthritis Rheum; 2006 Sep; 54(9):3001-10. PubMed ID: 16947625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.